Serving the Society Since 1986
Advanced Search
Volume 31 Issue 2
April 2016
    Citation: Xinxin Chen, Jifei Yang, Yanhong Ji, Edward Okoth, Bin Liu, Xiaoyang Li, Hong Yin, Qiyun Zhu. Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice .VIROLOGICA SINICA, 2016, 31(2) : 150-159.  http://dx.doi.org/10.1007/s12250-015-3692-2
    shu

    Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice

    • 1.

      State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China

    • 2.

      Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China

    • 3.

      International Livestock Research Institute, Nairobi 00100, Kenya

    • Corresponding author: Hong Yin, yinhong@caas.cn
      Qiyun Zhu, zhuqiyun@caas.cn
    • These authors contributed equally to this work.
    • Received Date: 28 November 2015
      Accepted Date: 25 January 2016
      Published Date: 10 March 2016
      Available online: 01 April 2016
    • African swine fever (ASF) is a lethal hemorrhagic disease that affects wild and domestic swine. The etiological agent of ASF is African swine fever virus (ASFV). Since the first case was described in Kenya in 1921, the disease has spread to many other countries. No commercial vaccines are available to prevent ASF. In this study, we generated a recombinant Newcastle disease virus (rNDV) expressing ASFV protein 72 (p72) by reverse genetics and evaluated its humoral and cellular immunogenicity in a mouse model. The recombinant virus, rNDV/p72, replicated well in embryonated chicken eggs and was safe to use in chicks and mice. The p72 gene in rNDV/p72 was stably maintained through ten passages. Mice immunized with rNDV/p72 developed high titers of ASFV p72 specific IgG antibody, and had higher levels of IgG1 than IgG2a. Immunization also elicited T-cell proliferation and secretion of IFN-γ and IL-4. Taken together, these results indicate that rNDV expressing ASFV p72 might be a potential vaccine candidate for preventing ASF.
    • 加载中

      1. Alexander DJ. 1989. Newcastle disease. Philadelphia: The American Association of Avian Pathologists, Inc. , pp114-120.

      2. Anis MM, Fulton SA, Reba SM, Harding CV, Boom WH. 2007. Modulation of naive CD4+ T-cell responses to an airway antigen during pulmonary mycobacterial infection. Infect Immun, 75: 2260-2268.
          doi: 10.1128/IAI.01709-06

      3. Argilaguet JM, P rez-Mart n E, L pez S, Goethe M, Escribano J, Giesow K, Keil GM, Rodr guez F. 2013. BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus. Antiviral Res, 98: 61-65.
          doi: 10.1016/j.antiviral.2013.02.005

      4. Argilaguet JM, Perez-Martin E, Nofrarias M, Gallardo C, Accensi F, Lacasta A, Mora M, Ballester M, Galindo-Cardiel I, Lopez-Soria S, Escribano JM, Reche PA, Rodriguez F. 2012. DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies. PLoS One, 7: e40942.
          doi: 10.1371/journal.pone.0040942

      5. Barderas M, Rodriguez F, Gomez-Puertas P, Aviles M, Beitia F, Alonso C, Escribano J. 2001. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch Virol, 146: 1681-1691.
          doi: 10.1007/s007050170056

      6. Boinas F, Hutchings G, Dixon L, Wilkinson P. 2004. Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal. J Gen Virol, 85: 2177-2187.
          doi: 10.1099/vir.0.80058-0

      7. Borca M, Irusta P, Carrillo C, Afonso C, Burrage T, Rock D. 1994. African swine fever virus structural protein p72 contains a conformational neutralizing epitope. Virology, 201: 413-418.
          doi: 10.1006/viro.1994.1311

      8. Bukreyev A, Huang Z, Yang L, Elankumaran S, Claire MS, Murphy BR, Samal SK, Collins PL. 2005. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol, 79: 13275-13284.
          doi: 10.1128/JVI.79.21.13275-13284.2005

      9. Callaway E. 2012. Pig fever sweeps across Russia. Nature, 488: 565-566.
          doi: 10.1038/488565a

      10. Carrascosa J, Gonz lez P, Carrascosa A, Garcia-Barreno B, Enjuanes L, Vinuela E. 1986. Localization of structural proteins in African swine fever virus particles by immunoelectron microscopy. J Virol, 58: 377-384.

      11. Costa JV. 1990. African swine fever virus. In: Molecular Biology of Iridoviruses. Darai G, ed. Vienna & New York: Springer-Verlag, pp247-270.

      12. Costard S, Wieland B, de Glanville W, Jori F, Rowlands R, Vosloo W, Roger F, Pfeiffer DU, Dixon LK. 2009a. African swine fever: how can global spread be prevented? Philosophical Transactions of the Royal Society B: Biological Sciences, 364: 2683-2696.
          doi: 10.1098/rstb.2009.0098

      13. Costard S, Wieland B, de Glanville W, Jori F, Rowlands R, Vosloo W, Roger F, Pfeiffer DU, Dixon LK. 2009b. African swine fever: how can global spread be prevented? Philos Trans R Soc Lond B Biol Sci, 364: 2683-2696.
          doi: 10.1098/rstb.2009.0098

      14. de Leeuw O, Peeters B. 1999. Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol, 80: 131-136.
          doi: 10.1099/0022-1317-80-1-131

      15. Dixon LK, Costa JV, Escribano JM, Rock DL, Vinuela E, Wilkinson PJ. 2000. In: The Asfarviridae. Van Regenmortel CMFMHV, Bishop DHL, Carsten EB, Estes MK, Lemon SM, Maniloff J, Mayo MA, McGeoch DJ, Pringle CR, Wickner RB. (Eds. ). New York: Academic Press, pp116-159.

      16. Eustace Montgomery R. 1921. On a form of swine fever occurring in British East Africa (Kenya Colony). J Comp Pathol Ther, 34: 159-191.
          doi: 10.1016/S0368-1742(21)80031-4

      17. Forman A, Wardley R, Wilkinson P. 1982. The immunological response of pigs and guinea pigs to antigens of African swine fever virus. Arch Virol, 74: 91-100.
          doi: 10.1007/BF01314703

      18. Gallardo C, Fern ndez-Pinero J, Pelayo V, Gazaev I, Markowska-Daniel I, Pridotkas G, Nieto R, Fern ndez-Pacheco P, Bokhan S, Nevolko O. 2014. Genetic variation among African swine fever genotype â…¡ viruses, eastern and central Europe. Emerg Infect Dis, 20: 1544.
          doi: 10.3201/eid2009.140554

      19. Ganar K, Das M, Sinha S, Kumar S. 2014. Newcastle disease virus: current status and our understanding. Virus Res, 184: 71-81.
          doi: 10.1016/j.virusres.2014.02.016

      20. Garcia-Barreno B, Sanz A, Nogal M, Vinuela E, Enjuanes L. 1986. Monoclonal antibodies of African swine fever virus: antigenic differences among field virus isolates and viruses passaged in cell culture. J Virol, 58: 385-392.

      21. Garcia-Escudero R, Andres G, Almazan F, Vinuela E. 1998. Inducible gene expression from African swine fever virus recombinants: analysis of the major capsid protein p72. J Virol, 72: 3185-3195.

      22. Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H. 2007. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol, 81: 150-158.
          doi: 10.1128/JVI.01514-06

      23. Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z. 2011. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol, 85: 8241-8252.
          doi: 10.1128/JVI.00519-11

      24. Ge J, Wang X, Tian M, Gao Y, Wen Z, Yu G, Zhou W, Zu S, Bu Z. 2015. Recombinant Newcastle disease viral vector expressing hemagglutinin or fusion of canine distemper virus is safe and immunogenic in minks. Vaccine, 33: 2457-2462.
          doi: 10.1016/j.vaccine.2015.03.091

      25. Hess WR. 1982. African swine fever: a reassessment. Adv Vet SciComp Med, 25: 39-69.

      26. Huang ZH, Krishnamurthy S, Panda A, Samal SK. 2001. High-level expression of a foreign gene from the most 3 '-proximal locus of a recombinant Newcastle disease virus. J Gen Virol, 82: 1729-1736.
          doi: 10.1099/0022-1317-82-7-1729

      27. Kim SH, Chen S, Jiang X, Green KY, Samal SK. 2014b. Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice. J Virol, 88: 9718-9727.
          doi: 10.1128/JVI.01570-14

      28. Kim SH, Paldurai A, Xiao S, Collins PL, Samal SK. 2014a. Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens. Vaccine, 32: 4428-4435.
          doi: 10.1016/j.vaccine.2014.06.061

      29. Kleiboeker SB, Scoles GA. 2001. Pathogenesis of African swine fever virus in Ornithodoros ticks. Amin Health Res Rev, 2: 121-128.

      30. Leitã o A, Cartaxeiro C, Coelho R, Cruz B, Parkhouse R, Portugal FC, Vig rio JD, Martins CL. 2001. The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. J Gen Virol, 82: 513-523.
          doi: 10.1099/0022-1317-82-3-513

      31. Leitã o A, Malur A, Cornelis P, Martins CL. 1998. Identification of a 25-aminoacid sequence from the major African swine fever virus structural protein VP72 recognised by porcine cytotoxic T lymphocytes using a lipoprotein based expression system. J Gen Virol, 75: 113-119.

      32. Neilan JG, Zsak L, Lu Z, Burrage TG, Kutish GF, Rock DL. 2004. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology, 319: 337-342.
          doi: 10.1016/j.virol.2003.11.011

      33. Onisk D, Borca M, Kutish S, Kramer E, Irusta P, Rock D. 1994. Passively transferred African swine fever virus antibodies protect swine against lethal infection. Virology, 198: 350-354.
          doi: 10.1006/viro.1994.1040

      34. Oura C, Denyer M, Takamatsu H, Parkhouse R. 2005. In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. J Gen Virol, 86: 2445-2450.
          doi: 10.1099/vir.0.81038-0

      35. Pejsak Z, Truszczyński M, Niemczuk K, Kozak E, Markowska-Daniel I. 2014. Epidemiology of African Swine Fever in Poland since the detection of the first case. Pol J Vet Sci, 17: 665-672.

      36. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am J Epidemiol, 27: 493-497.
          doi: 10.1093/oxfordjournals.aje.a118408

      37. Rowlands RJ, Michaud V, Heath L, Hutchings G, Oura C, Vosloo W, Dwarka R, Onashvili T, Albina E, Dixon LK. 2008. African swine fever virus isolate, Georgia, 2007. Emerg Infect Dis, 14: 1870-1874.
          doi: 10.3201/eid1412.080591

      38. Salas J, Salas M, Vinuela E. 1999. Chapter 18-African swine fever virus: a missing link between poxviruses and iridoviruses. In: Origin and Evolution of Viruses. Esteban Domingo, Robert Webster and John Holland. Elsevier: Academic Press, pp 467-480.

      39. Schnell MJ, Mebatsion T, Conzelmann K-K. 1994. Infectious rabies viruses from cloned cDNA. EMBO J, 13: 4195.

      40. Wyatt LS, Moss B, Rozenblatt S. 1995. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology, 210: 202-205.
          doi: 10.1006/viro.1995.1332

      41. Ye L, Lin J, Sun Y, Bennouna S, Lo M, Wu Q, Bu Z, Pulendran B, Compans RW, Yang C. 2006. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology, 351: 260-270.
          doi: 10.1016/j.virol.2006.03.021

    • 加载中

    Figures(6) / Tables(1)

    PDF

    Article Metrics

    Article views(7218) PDF downloads(38) Cited by()

    Related
    Proportional views

      Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice

        Corresponding author: Hong Yin, yinhong@caas.cn
        Corresponding author: Qiyun Zhu, zhuqiyun@caas.cn
      • 1. State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China
      • 2. Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, China
      • 3. International Livestock Research Institute, Nairobi 00100, Kenya
      • Received Date: 28 November 2015
      • Accepted Date: 25 January 2016
      • Published Date: 10 March 2016

      Abstract: African swine fever (ASF) is a lethal hemorrhagic disease that affects wild and domestic swine. The etiological agent of ASF is African swine fever virus (ASFV). Since the first case was described in Kenya in 1921, the disease has spread to many other countries. No commercial vaccines are available to prevent ASF. In this study, we generated a recombinant Newcastle disease virus (rNDV) expressing ASFV protein 72 (p72) by reverse genetics and evaluated its humoral and cellular immunogenicity in a mouse model. The recombinant virus, rNDV/p72, replicated well in embryonated chicken eggs and was safe to use in chicks and mice. The p72 gene in rNDV/p72 was stably maintained through ten passages. Mice immunized with rNDV/p72 developed high titers of ASFV p72 specific IgG antibody, and had higher levels of IgG1 than IgG2a. Immunization also elicited T-cell proliferation and secretion of IFN-γ and IL-4. Taken together, these results indicate that rNDV expressing ASFV p72 might be a potential vaccine candidate for preventing ASF.

        HTML

      INTRODUCTION